Polar Asset Management Partners Inc. Viridian Therapeutics, Inc.\De Transaction History
Polar Asset Management Partners Inc.
- $3.16 Billion
- Q2 2024
A detailed history of Polar Asset Management Partners Inc. transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Polar Asset Management Partners Inc. holds 109,900 shares of VRDN stock, worth $2.56 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
109,900
Previous 111,400
1.35%
Holding current value
$2.56 Million
Previous $1.95 Million
26.72%
% of portfolio
0.05%
Previous 0.04%
Shares
7 transactions
Others Institutions Holding VRDN
# of Institutions
149Shares Held
60.7MCall Options Held
134KPut Options Held
238K-
Black Rock Inc. New York, NY4.77MShares$111 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.92MShares$91.5 Million1.68% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$90.6 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$78.1 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.31MShares$77.2 Million0.85% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $931M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...